Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

InspireMD (NSPR) Return on Sales (2016 - 2025)

Historic Return on Sales for InspireMD (NSPR) over the last 16 years, with Q3 2025 value amounting to 5.17%.

  • InspireMD's Return on Sales fell 5000.0% to 5.17% in Q3 2025 from the same period last year, while for Sep 2025 it was 6.03%, marking a year-over-year decrease of 16400.0%. This contributed to the annual value of 4.57% for FY2024, which is 13600.0% down from last year.
  • InspireMD's Return on Sales amounted to 5.17% in Q3 2025, which was down 5000.0% from 7.32% recorded in Q2 2025.
  • Over the past 5 years, InspireMD's Return on Sales peaked at 2.94% during Q4 2021, and registered a low of 7.5% during Q1 2025.
  • For the 5-year period, InspireMD's Return on Sales averaged around 4.25%, with its median value being 3.79% (2022).
  • As far as peak fluctuations go, InspireMD's Return on Sales surged by 206000bps in 2021, and later crashed by -25900bps in 2025.
  • Quarter analysis of 5 years shows InspireMD's Return on Sales stood at 2.94% in 2021, then crashed by -60bps to 4.69% in 2022, then increased by 30bps to 3.3% in 2023, then tumbled by -46bps to 4.81% in 2024, then fell by -8bps to 5.17% in 2025.
  • Its last three reported values are 5.17% in Q3 2025, 7.32% for Q2 2025, and 7.5% during Q1 2025.